Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

LMNX - Luminex Corp

Close
36.99
0.010   0.027%

Share volume: 0
Last Updated: Tue 13 Jul 2021 10:00:01 PM CEST
Testing Laboratories: -4.68%

PREVIOUS CLOSE
CHG
CHG%
$36.98
0.01
0.03%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
73%
Profitability 78%
Dept financing 32%
Liquidity 75%
Performance 78%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$36.99
P/E Ratio 
0.00
DAY RANGE
$36.98 - $37.00
EPS 
$0.50
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
47.314 M
DIVIDEND
$0.10
EX-DIVIDEND DATE
06/16/2021
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO: Nachum Shamir
Region: US
Website: www.luminexcorp.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Testing Laboratories
Sector: Professional, Scientific, and Technical Services

The mission of Luminex is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. The Company offers a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. Luminex accelerates reliable answers while simplifying complexity and deliver certainty with a seamless experience.

Recent news